Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Ketamine hydrochloride
Pfizer Healthcare Ireland
N01AX; N01AX03
Ketamine hydrochloride
10 milligram(s)/millilitre
Solution for injection/infusion
Product subject to prescription which may not be renewed (A)
Other general anesthetics; ketamine
Marketed
1980-04-01
Page 1 of 10 2023-0086367 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT KETALAR ® 10 MG/ML SOLUTION FOR INJECTION / INFUSION KETALAR ® 50 MG/ML SOLUTION FOR INJECTION / INFUSION KETAMINE HYDROCHLORIDE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • If you have been given Ketalar in an emergency you will not have had a chance to read this leaflet. Your doctor or anaesthetist will have considered the important safety information in this leaflet, but your urgent need for treatment may have been more important than some of the usual precautions. • If you are discharged on the same day as the operation, you should be accompanied by another adult. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or nurse. • If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. See section 4.4. _ _ WHAT IS IN THIS LEAFLET 1. WHAT KETALAR INJECTION IS AND WHAT IT IS USED FOR 2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN KETALAR INJECTION 3. HOW KETALAR INJECTION IS GIVEN 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE KETALAR INJECTION 6. CONTENTS OF THE PACK AND OTHER INFORMATION 1. WHAT KETALAR INJECTION IS AND WHAT IT IS USED FOR ▪ This medicine contains ketamine hydrochloride which belongs to a group of medicines called anaesthetic agents, which are used to put you to sleep during an operation. Ketalar may be used in both routine and emergency surgery. ▪ Ketalar is used in adults, the elderly and children. ▪ Ketalar can be given alone or in combination with other anaesthetic agents. 2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN KETALAR INJECTION DO NOT TAKE KETALAR: • if you are allergic (hypersensitivity) to ketamine hydrochloride or any of the other ingredients of this medicine (listed in section 6). • if you are suffering from any condition in which an increase in blood pressure may be harmful to you or have suffe Read the complete document
Health Products Regulatory Authority 20 February 2024 CRN00D6VD Page 1 of 11 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Ketalar 10mg/ml Solution for Injection/Infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Ketamine hydrochloride equivalent to 10 mg ketamine base per ml. A 20 ml solution contains ketamine hydrochloride equivalent to 200 mg ketamine base. Excipient with known effect: Ketalar 10mg/ml contains 53 mg of sodium per 20 ml of solution. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection or infusion A clear, colourless, aqueous solution for injection or infusion. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Ketamine is indicated in children and in adults. 1. As an anaesthetic agent for short diagnostic and surgical procedures which do not require skeletal muscle relaxation. 2. For the induction of anaesthesia prior to the administration of other general anaesthetic agents. 3. To supplement other anaesthetic agents. Specific areas of application or types of procedures: 1. When the intramuscular route of administration is more convenient. 2. Debridement, painful dressings, and skin grafting in burned patients, as well as other superficial surgical procedures. 3. For certain neurological, radiodiagnostic and therapeutic procedures in children to abolish movement. 4. When airway control is difficult. NOTE: Ketamine should be used only with caution in surgical procedures involving pharynx, larynx or trachea as it increases salivary and tracheo-bronchial secretions and does not reliably suppress pharyngeal or laryngeal reflexes. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For intravenous infusion, intravenous injection or intramuscular injection. NOTE: ALL DOSES ARE GIVEN IN TERMS OF KETAMINE BASE Ketalar is not indicated nor recommended for long term use (see sections 4.1 and 4.4). _Adults, elderly (over 65 years) and children_ Health Products Regulatory Authority 20 February 2024 CRN00D6VD Page 2 of 11 For surgery in elderly patients Read the complete document